Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-285564

Chief Medical Officer sold 10,035 shares at $45.03 ($451,876)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Karlin Daniel Chief Medical Officer 2026-06-25 Sale 10b5-1 −10,035 $45.03 $451,876 503,282 D: show line 1 in the form
Open-market sales · 10,035 sh · avg $45.03 · $451,876
Loading xslF345X06/ownership.xml…